Dzmitry Mukha

954 citations
19 papers · 680 indexed · h-index 11
Topics
Pharmacogenetics and Drug Metabolism (5 papers)Cancer, Hypoxia, and Metabolism (3 papers)Computational Drug Discovery Methods (3 papers)
Partner nations
BelarusRussiaIsrael

In The Last Decade

Dzmitry Mukha

19 papers receiving 673 citations

Peers

Dzmitry Mukha
Comparison fields: 5 of 96
  • Molecular Biology 336
  • Pharmacology 194
  • Plant Science 131
  • Cancer Research 106
  • Spectroscopy 67
Replace Xiaolan Shen with:
Xiaolan Shen United States
Andrew K.L. Goey United States
Joel Cassel United States
Paul V. Kaplita United States
Roberta Ottria Italy
Émilie Durieu France
Monica Singer United States
Ilaria Genovese Italy
Chhanda Bose United States
Kerryn McCluskie United States
Dzmitry Mukha relative to Xiaolan Shen United States Xiaolan Shen's profile →
Citations per field
00.5×3.5×
Xiaolan Shen · 1×
Citations per year

Countries citing papers authored by Dzmitry Mukha

Since Specialization
Citations

This map shows the geographic impact of Dzmitry Mukha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dzmitry Mukha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dzmitry Mukha more than expected).

Fields of papers citing papers by Dzmitry Mukha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dzmitry Mukha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dzmitry Mukha. The network helps show where Dzmitry Mukha may publish in the future.

Co-authorship network of co-authors of Dzmitry Mukha

This figure shows the co-authorship network connecting the top 25 collaborators of Dzmitry Mukha. A scholar is included among the top collaborators of Dzmitry Mukha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dzmitry Mukha. Dzmitry Mukha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 5
2 5
3 78
4 37
5 56
6 40
7 53
8 38
9 208
10 62
11 1
12 3
13 33
14 6
15 23
16 6
17 2
18 18
19 6

About Dzmitry Mukha

Dzmitry Mukha is a scholar working on Pharmacology, Clinical Biochemistry and Biochemistry, having authored 19 papers that have together received 680 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Computational Drug Discovery Methods (3 papers). The work is most often cited by research in Pharmacology (194 citations), Toxicology (32 citations) and Cancer Research (106 citations). Dzmitry Mukha has collaborated with scholars based in Belarus, Russia and Israel. Frequent co-authors include Tomer Shlomi, Maya Benami, David Meiri, Paula Berman, Gil M. Lewitus, É. M. Aizenshtein, Praveen Kumar, Won Dong Lee, Amit Tzur and Sergey A. Usanov. Their work appears in journals such as Nature Communications, Cell Metabolism and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026